Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Polliana B Dos Santos, Rodrigo P Simões, Cássia da L Goulart, Meliza G Roscani, Renan S Marinho, Patrícia Faria Camargo, Renata F Arbex, Guilherme Casale, Cláudio R Oliveira, Renata G Mendes, Ross Arena & Audrey Borghi-Silva. (2021) Eccentric Left Ventricular Hypertrophy and Left and Right Cardiac Function in Chronic Heart Failure with or without Coexisting COPD: Impact on Exercise Performance. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 203-214.
Read now
Read now
Peter Lange, David M Halpin, Denis E O’Donnell & William MacNee. (2016) Diagnosis, assessment, and phenotyping of COPD: beyond FEV1. International Journal of Chronic Obstructive Pulmonary Disease 11:sup1, pages 3-12.
Read now
Read now
Annabelle Couillard, Jean François Muir & Daniel Veale. (2010) COPD Recent Findings: Impact on Clinical Practice. COPD: Journal of Chronic Obstructive Pulmonary Disease 7:3, pages 204-213.
Read now
Read now
Articles from other publishers (25)
Norah Alruwaili, Sharath Kandhi, Ghezal Froogh, Melissa R. Kelly, Dong Sun & Michael S. Wolin. (2023) Superoxide-Mediated Upregulation of MMP9 Participates in BMPR2 Destabilization and Pulmonary Hypertension Development. Antioxidants 12:11, pages 1961.
Crossref
Crossref
Ratoe Suraya, Tatsuya Nagano, Gusty Rizky Teguh Ryanto, Wiwin Is Effendi, Daisuke Hazama, Naoko Katsurada, Masatsugu Yamamoto, Motoko Tachihara, Noriaki Emoto, Yoshihiro Nishimura & Kazuyuki Kobayashi. (2022) Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFκB inactivation. Respiratory Research 23:1.
Crossref
Crossref
Helen Christou & Raouf A. Khalil. (2022) Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies. American Journal of Physiology-Heart and Circulatory Physiology 322:5, pages H702-H724.
Crossref
Crossref
Helen Christou, Zoe Michael, Fotios Spyropoulos, Yunfei Chen, Dan Rong & Raouf A. Khalil. (2021) Carbonic anhydrase inhibition improves pulmonary artery reactivity and nitric oxide-mediated relaxation in sugen-hypoxia model of pulmonary hypertension. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 320:6, pages R835-R850.
Crossref
Crossref
Marija Gredic, Isabel Blanco, Gabor Kovacs, Zsuzsanna Helyes, Péter Ferdinandy, Horst Olschewski, Joan Albert Barberà & Norbert Weissmann. (2020) Pulmonary hypertension in chronic obstructive pulmonary disease. British Journal of Pharmacology 178:1, pages 132-151.
Crossref
Crossref
Shay Brikman & Guy Dori. (2020) Sodium glucose cotransporter2 inhibitor-possible treatment for patients with diabetes, pulmonary disease and CO2 retention. Medical Hypotheses 139, pages 109631.
Crossref
Crossref
Helen Christou, Hannes Hudalla, Zoe Michael, Evgenia J. Filatava, Jun Li, Minglin Zhu, Jose S. Possomato-Vieira, Carlos Dias-Junior, Stella Kourembanas & Raouf A. Khalil. (2018) Impaired Pulmonary Arterial Vasoconstriction and Nitric Oxide–Mediated Relaxation Underlie Severe Pulmonary Hypertension in the Sugen-Hypoxia Rat Model. Journal of Pharmacology and Experimental Therapeutics 364:2, pages 258-274.
Crossref
Crossref
Anthony M. Szema, Edward Forsyth, Benjamin Ying, Sayyed A. Hamidi, John J. Chen, Sonya Hwang, Jonathan C. Li, Debra Sabatini Dwyer, Juan M. Ramiro-Diaz, Wieslawa Giermakowska & Laura V. Gonzalez Bosc. (2017) NFATc3 and VIP in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease. PLOS ONE 12:1, pages e0170606.
Crossref
Crossref
Abubakr A. Bajwa, Adil Shujaat, Minal Patel, Colleen Thomas, Franck Rahaghi & Charles D. Burger. (2017) The safety and tolerability of inhaled treprostinil in patients with pulmonary hypertension and chronic obstructive pulmonary disease. Pulmonary Circulation 7:1, pages 82-88.
Crossref
Crossref
Norbert F. Voelkel, Shiro Mizuno & Carlyne D. Cool. 2017. COPD. COPD
195
207
.
Yali Wang, Feng Hu, Xiaoyan Mu, Feng Wu, Dechun Yang, Guixiang Zheng, Xiaoning Sun, Kaizheng Gong & Zhengang Zhang. (2016) Protective effects of drag-reducing polymers in a rat model of monocrotaline-induced pulmonary hypertension. Biorheology 53:1, pages 13-22.
Crossref
Crossref
Janos Varga, Attila Palinkas, Imre Lajko, Ildikó Horváth, Krisztina Boda & Attila Somfay. (2016) Pulmonary Arterial Pressure Response During Exercise in COPD: A Correlation with C-Reactive Protein (hsCRP). The Open Respiratory Medicine Journal 10:1, pages 1-11.
Crossref
Crossref
Sebastian Reimann, Ludger Fink, Jochen Wilhelm, Julia Hoffmann, Mariola Bednorz, Michael Seimetz, Isabel Dessureault, Roger Troesser, Bahil Ghanim, Walter Klepetko, Werner Seeger, Norbert Weissmann & Grazyna Kwapiszewska. (2015) Increased S100A4 expression in the vasculature of human COPD lungs and murine model of smoke-induced emphysema. Respiratory Research 16:1.
Crossref
Crossref
Ellen Hillegass, Ann Fick, Amy Pawlik, Rebecca Crouch, Christiane Perme, Rohini Chandrashekar, Susan Butler McNamara & Lawrence P. Cahalin. (2014) Supplemental Oxygen Utilization During Physical Therapy Interventions. Cardiopulmonary Physical Therapy Journal 25:2, pages 38-49.
Crossref
Crossref
Elizabeth S. Klings, Roberto F. Machado, Robyn J. Barst, Claudia R. Morris, Kamal K. Mubarak, Victor R. Gordeuk, Gregory J. Kato, Kenneth I. Ataga, J. Simon Gibbs, Oswaldo Castro, Erika B. Rosenzweig, Namita Sood, Lewis Hsu, Kevin C. Wilson, Marilyn J. Telen, Laura M. DeCastro, Lakshmanan Krishnamurti, Martin H. Steinberg, David B. Badesch & Mark T. Gladwin. (2014) An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease. American Journal of Respiratory and Critical Care Medicine 189:6, pages 727-740.
Crossref
Crossref
Mikkel Malby Schoos, Morten Dalsgaard, Jesper Kjærgaard, Dorte Moesby, Sidse Graff Jensen, Ida Steffensen & Kasper Karmark Iversen. (2013) Echocardiographic predictors of exercise capacity and mortality in chronic obstructive pulmonary disease. BMC Cardiovascular Disorders 13:1.
Crossref
Crossref
Wilawan Thirapatarapong, Hilary F. Armstrong, Byron M. Thomashow & Matthew N. Bartels. (2013) Differences in gas exchange between severities of chronic obstructive pulmonary disease. Respiratory Physiology & Neurobiology 186:1, pages 81-86.
Crossref
Crossref
Wim Timens, Hannie Sietsma & Joanne L. Wright. 2014. Spencer's Pathology of the Lung. Spencer's Pathology of the Lung
605
660
.
Robert P. Frantz & Michael D. McGoon. (2012) Diagnostic Dilemmas in Pulmonary Hypertension. Heart Failure Clinics 8:3, pages 331-352.
Crossref
Crossref
Helen Christou, Ossama M. Reslan, Virak Mam, Alain F. Tanbe, Sally H. Vitali, Marlin Touma, Elena Arons, S. Alex Mitsialis, Stella Kourembanas & Raouf A. Khalil. (2012) Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology 302:9, pages L875-L890.
Crossref
Crossref
Mitra Esfandiarei, Julia T. N. Lam, Sahar Abdoli Yazdi, Amina Kariminia, Jorge Navarro Dorado, Boris Kuzeljevic, Harley T. Syyong, Kaiji Hu & Cornelis van Breemen. (2011) Diosgenin Modulates Vascular Smooth Muscle Cell Function by Regulating Cell Viability, Migration, and Calcium Homeostasis. Journal of Pharmacology and Experimental Therapeutics 336:3, pages 925-939.
Crossref
Crossref
Neal M. Patel & Charles D. Burger. (2011) Two cases of stem cell therapy for pulmonary hypertension: A clinical report. Respiratory Medicine CME 4:2, pages 70-74.
Crossref
Crossref
C. Gregory Elliott, Robyn J. Barst, Werner Seeger, Mateo Porres-Aguilar, Lynette M. Brown, Roham T. Zamanian & Lewis J. Rubin. (2010) Worldwide Physician Education and Training in Pulmonary Hypertension. Chest 137:6, pages 85S-94S.
Crossref
Crossref
Jonathan De Blois, Serge Simard, Dan Atar & Stefan Agewall. (2010) COPD Predicts Mortality in HF: The Norwegian Heart Failure Registry. Journal of Cardiac Failure 16:3, pages 225-229.
Crossref
Crossref
V. Mam, A. F. Tanbe, S. H. Vitali, E. Arons, H. A. Christou & R. A. Khalil. (2009) Impaired Vasoconstriction and Nitric Oxide-Mediated Relaxation in Pulmonary Arteries of Hypoxia- and Monocrotaline-Induced Pulmonary Hypertensive Rats. Journal of Pharmacology and Experimental Therapeutics 332:2, pages 455-462.
Crossref
Crossref